Frequency of Malignancy in Clinically Benign Breast Lump

Shaista  Sindhu; Ishrat Rahim  Katiar; Shahida  Khatoon; Syed Amir  Shah; Kapil  Dev; Saddam Hussain  Katiar

doi:10.54112/bcsrj.v6i6.1799

Authors

Shaista Sindhu Department of General Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Ishrat Rahim Katiar Department of General Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Shahida Khatoon Department of General Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Syed Amir Shah Department of General Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Kapil Dev Department of General Surgery, Combined Military Hospital, Hyderabad, Pakistan
Saddam Hussain Katiar Department of General Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i6.1799

Keywords:

Clinically palpable, benign breast lump, malignancy

Abstract

Breast lumps are among the most common presentations in surgical clinics, and while many are benign, a significant proportion may harbor malignancy. Clinical assessment alone may not reliably differentiate benign from malignant lesions, necessitating histopathological confirmation to guide appropriate management. Objective: To determine the frequency of malignancy in clinically benign breast lumps. Study design: Cross-sectional study. Place and duration: Department of General Surgery, Liaquat University of Medical and Health Sciences, Jamshoro, for 6 months, i.e., from September 2024 to February 2025. Methods: A total of 143 patients who fulfilled the selection criteria were included. At baseline, the demographic profile, clinical history, and physical examination of all patients were carried out, and findings were not noted down on a predesigned proforma by the researcher herself. Risk factors for malignancy were assessed in all patients. All patients were then subjected to core needle biopsy of the breast lump. Specimens were sent for histopathological evaluation, and findings were noted down and subjected to statistical analysis. Results: The median (IQR) age of the patients was 52 (16) years. The median (IQR) BMI was 25.4 (4.8) kg/m2. The median (IQR) duration of BBL was 4 (2) months. Among patients with BLL, malignancy was reportedly present in 28 (19.6%) patients. Conclusion: In patients with benign breast lesions, malignancy was reported in 28 (19.6%) patients.

Downloads

Download data is not yet available.

References

Iqbal M, Iqbal M, Kamal F. The frequency of malignancy in breast lumps on FNAc in females under 35 years of age. Ann King Edward Med Univ. 2014;20(1):13-18.

Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. Radiol. 2010;255(3):731-737.

Mohammed AA. Benign breast disorders in female. Rev Senol Patol Mamar. 2022;35(1):42-48.

Singh SB, Chakrabarti N. A clinicopathological study of benign breast diseases in females. Med J Dr D Y Patil University. 2022;15(3):346-351.

Mohrmann S, Maier-Bode A, Dietzel F, Reinecke P, Krawczyk N, Kaleta T, et al. Malignancy rate and malignancy risk assessment in different lesions of uncertain malignant potential in the breast (B3 lesions): an analysis of 192 cases from a single institution. Breast Care. 2022;17(2):159-165.

Menhas R, Shumaila UM. Breast cancer among Pakistani women. Iran J Public Health. 2015;44(4):586-587.

Heng SS, Yahya MM, Sulaiman WA, Saad AZ. A harmless evil: Giant fungating benign breast mass in an adolescent mimicking malignancy-Case report. Int J Surg Case Rep. 2021;80:105202.

Catanzariti F, Avendano D, Cicero G, Garza-Montemayor M, Sofia C, Venanzi Rullo E, et al. High-risk lesions of the breast: concurrent diagnostic tools and management recommendations. Insights Imaging. 2021;12(1):63.

Malherbe K. Benign Diseases of the Breast. A Mammographer's Guide: Radiological and Histopathological Guidelines. 2025:53-86.

Menhas R, Shumaila UM. Breast cancer among Pakistani women. Iran J Public Health. 2015;44(4):586-587.

Shah AZ, Zeb A, Zeb A, Jehan S, Roghani AS, Khan JUA. Beneath the surface: uncovering malignancy in benign breast lumps. J Popul Ther Clin Pharm. 2024;31(7):1854-1860.

Abbas AK. The incidence of malignancy in breast lumps in females: A prospective population study. Pak J Med Health Sci. 2021;15(7):2371-2373.

Abbasi F, Zia MK, Usmani MS, Majeed S, Tahseen H, Khan IA. Frequency of Clinically Palpable Breast Lumps in an Urban Medical Center Importance of a Surgeon Run Breast Clinic. Pak J Med Health Sci. 2023;17(02):414-416.

Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. New Engl J Med. 2005;353(3):229-237.

Selvakumaran S, Sangma MB. Study of various benign breast diseases. Int Surg J. 2017;4(1):339-343.

Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, et al. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening. Eur Radiol. 2022;32(1):621-629.

Román M, Louro J, Posso M, Alcántara R, Peñalva L, Sala M, et al. Breast density, benign breast disease, and risk of breast cancer over time. Eur Radiol. 2021;31:4839-4847.

Limberg J, Kucher W, Fasano G, Hoda S, Michaels A, Marti JL. Intraductal papilloma of the breast: prevalence of malignancy and natural history under active surveillance. Ann Surg Oncol. 2021;28:6032-6040.

Kim S, Tran TX, Song H, Ryu S, Chang Y, Park B. Mammographic breast density, benign breast disease, and subsequent breast cancer risk in 3.9 million Korean women. Radiol. 2022;304(3):534-541.

de Blok CJ, Dijkman BA, Wiepjes CM, Konings IR, Dreijerink KM, Barbé E, et al. Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study. Breast. 2021;57:118-122.